Forbion News | Archief

• AMT Announces Positive Interim Clincal Data on its Lead Product AMT-011 06.25.2008
• AMT prepares for submission of Marketing Authorization Dossier for AMT-011 (Glybera®) 06.25.2008
• Biovex reports positive phase II clinical trial results of Oncovex GM-CSF in metastatic melanoma at the 2008 American Society of Clinical Oncology Meeting 06.25.2008

Portfolio Company News | Archief

• Argos Therapeutics Secures $35.2 Million Series C Financing 04.23.2008

Events

You can meet the Forbion team at one of the following events:

• BioSpain 2008 »
  Granada: 09.17.2008 - 09.18.2008
• Bio-Europe 2008 »
  Mannheim/Heidelberg, Germany: 11.17.2008 - 11.19.2008
• SuperInvestor 2008 »
  Paris, Westin Hotel: 11.18.2008 - 11.21.2008

© Forbion 2006 All rights reserved